← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 31, 2021Last known activity
Dec 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (9)
- NCT07240467CollaboratorPhase 2/Phase 3Dec 15, 2025
- NCT07019012CollaboratorPhase 4Jul 30, 2025
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT05909098Sponsor investigatorPhase 1/Phase 2Jul 1, 2023
- NCT05909098OfficialPhase 1/Phase 2Jul 1, 2023
- NCT05909098Lead sponsorPhase 1/Phase 2Jul 1, 2023
- NCT05909098Overall official - principal investigatorPhase 1/Phase 2Jul 1, 2023
- NCT05909098Reponsible party - principal investigatorPhase 1/Phase 2Jul 1, 2023
- NCT05159947CollaboratorPhase 3Dec 31, 2021
Details
- Last known activity
- Dec 15, 2025